Literature DB >> 12061508

The globus pallidus, deep brain stimulation, and Parkinson's disease.

Jonathan O Dostrovsky1, William D Hutchison, Andres M Lozano.   

Abstract

Parkinson's disease (PD) is caused by the degeneration of the dopaminergic neurons in the substantia nigra. Loss of dopaminergic innervation leads to hyperactivity in the internal segment of the globus pallidus (GPi), the main output nucleus of the basal ganglia and to a profound disturbance in the function of motor circuits. Lesions of the GPi (or in its upstream modulator, the subthalamic nucleus) can greatly improve the motor symptoms of PD presumably by reducing this pathological activity. Paradoxically, high-frequency electrical stimulation of the GPi (deep brain stimulation, DBS) mimics the effects of pallidotomy and has become an accepted therapeutic technique. The mechanisms underlying the beneficial effects of pallidal DBS are not known. Various mechanisms that might account for inhibiting or disrupting the pathological pallidal outflow by high-frequency DBS have been proposed ranging from depolarization block to stimulation-evoked release of GABA, and these are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061508     DOI: 10.1177/1073858402008003014

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  9 in total

1.  Point process models show temporal dependencies of basal ganglia nuclei under deep brain stimulation.

Authors:  Shreya Saxena; Sabato Santaniello; Erwin B Montgomery; John T Gale; Sridevi V Sarma
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

2.  Hemispheric Asymmetry of Globus Pallidus Relates to Alpha Modulation in Reward-Related Attentional Tasks.

Authors:  Cecilia Mazzetti; Tobias Staudigl; Tom R Marshall; Johanna M Zumer; Sean J Fallon; Ole Jensen
Journal:  J Neurosci       Date:  2019-10-02       Impact factor: 6.167

3.  Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.

Authors:  Yasushi Takagi; Jun Takahashi; Hidemoto Saiki; Asuka Morizane; Takuya Hayashi; Yo Kishi; Hitoshi Fukuda; Yo Okamoto; Masaomi Koyanagi; Makoto Ideguchi; Hideki Hayashi; Takayuki Imazato; Hiroshi Kawasaki; Hirofumi Suemori; Shigeki Omachi; Hidehiko Iida; Nobuyuki Itoh; Norio Nakatsuji; Yoshiki Sasai; Nobuo Hashimoto
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

Review 4.  Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease.

Authors:  Muthuraman Muthuraman; Nabin Koirala; Dumitru Ciolac; Bogdan Pintea; Martin Glaser; Stanislav Groppa; Gertrúd Tamás; Sergiu Groppa
Journal:  Front Neurol       Date:  2018-08-27       Impact factor: 4.003

5.  Simulating the effects of short-term synaptic plasticity on postsynaptic dynamics in the globus pallidus.

Authors:  Moran Brody; Alon Korngreen
Journal:  Front Syst Neurosci       Date:  2013-08-08

6.  Deep brain stimulation in Parkinson's disease.

Authors:  Raja Mehanna; Eugene C Lai
Journal:  Transl Neurodegener       Date:  2013-11-18       Impact factor: 8.014

7.  Uncovering the underlying mechanisms and whole-brain dynamics of deep brain stimulation for Parkinson's disease.

Authors:  Victor M Saenger; Joshua Kahan; Tom Foltynie; Karl Friston; Tipu Z Aziz; Alexander L Green; Tim J van Hartevelt; Joana Cabral; Angus B A Stevner; Henrique M Fernandes; Laura Mancini; John Thornton; Tarek Yousry; Patricia Limousin; Ludvic Zrinzo; Marwan Hariz; Paulo Marques; Nuno Sousa; Morten L Kringelbach; Gustavo Deco
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

8.  Computational prediction of changes in brain metabolic fluxes during Parkinson's disease from mRNA expression.

Authors:  Farahaniza Supandi; Johannes H G M van Beek
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

9.  Basal ganglia role in learning rewarded actions and executing previously learned choices: Healthy and diseased states.

Authors:  Garrett Mulcahy; Brady Atwood; Alexey Kuznetsov
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.